Allogene Therapeutics
ALLO
ALLO
165 hedge funds and large institutions have $2.26B invested in Allogene Therapeutics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 71 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 162 → 165 (+3)
2% less call options, than puts
Call options by funds: $3.15M | Put options by funds: $3.23M
30% less capital invested
Capital invested by funds: $3.21B → $2.26B (-$957M)
Holders
165
Holding in Top 10
5
Calls
$3.15M
Puts
$3.23M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$29.3M | |
| 3 | +$26.4M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$21.3M |
| 5 |
Goldman Sachs
New York
|
+$17.9M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$17M | |
| 3 | -$12.4M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$9.58M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$8.46M |